Generated by GPT-5-mini| TRIUMF ISAC | |
|---|---|
| Name | ISAC |
| Established | 1998 |
| Location | Vancouver, British Columbia, Canada |
| Operator | TRIUMF |
| Type | Radioactive ion beam facility |
TRIUMF ISAC is a radioactive ion beam (RIB) facility located at TRIUMF in Vancouver, British Columbia, Canada that provides isotopically enriched beams for basic and applied research. It serves nuclear physics, nuclear astrophysics, materials science, and medical isotope communities by coupling a high-current proton driver with isotope production and post-acceleration systems. The facility integrates collaborations with universities, national laboratories, and international projects to enable experiments in spectroscopy, decay studies, and applied radiochemistry.
ISAC operates as an isotope production and post-acceleration complex adjacent to TRIUMF's cyclotron, supporting experiments from laboratories such as University of British Columbia, Simon Fraser University, McGill University, and national partners like Canadian Nuclear Laboratories. The program interfaces with international facilities including CERN, GSI Helmholtz Centre for Heavy Ion Research, RIKEN, and Argonne National Laboratory, enabling comparative studies in nuclear structure, nuclear astrophysics, and isotope applications. Governance and funding involve agencies and institutions such as Natural Sciences and Engineering Research Council of Canada, Canadian Institutes of Health Research, and provincial research councils, linking to broader networks including the National Research Council (Canada) and transnational consortia.
ISAC's infrastructure is anchored by a high-intensity 520 MeV proton beam from the TRIUMF cyclotron, interfacing with target stations and low-energy beamlines; technical partners and equipment suppliers include groups from Brookhaven National Laboratory, Lawrence Berkeley National Laboratory, and TRIUMF engineering teams. Beam handling employs magnetic isotope separators, radiofrequency quadrupoles (RFQ), and superconducting linear accelerators similar to developments at CERN ISOLDE and SPES (facility), with diagnostics derived from collaborations with Oak Ridge National Laboratory and Paul Scherrer Institute. Ion source technology, electrostatic beam transport, and beam purification use techniques comparable to designs at ISOLDE, GANIL, and ISAC II, integrating expertise from accelerator physicists connected with University of Toronto and McMaster University.
Radioisotope production uses proton-induced spallation and fission on thick targets composed of materials such as uranium carbide, tantalum, and graphite, following target development efforts akin to those at École Polytechnique, Los Alamos National Laboratory, and Helmholtz-Zentrum Dresden-Rossendorf. On-line isotope separation adapts ISOL (isotope separation online) methods implemented at ISOLDE, with target ion-source systems informed by research groups at TRIUMF and CERN. Target handling, remote manipulation, and hot-cell capabilities rely on partnerships with Canadian Nuclear Laboratories and equipment standards from International Atomic Energy Agency safety frameworks. Radioisotopes produced have been used in studies connected to phenomena investigated by teams at Max Planck Institute for Nuclear Physics, University of Manchester, and University of Jyväskylä.
ISAC hosts experimental stations for decay spectroscopy, mass measurements, laser spectroscopy, and reaction studies, deploying devices and detector collaborations with TRIUMF Centre for Molecular and Materials Science, SNOLAB, and the National Superconducting Cyclotron Laboratory. Instruments include Penning traps and multi-reflection time-of-flight spectrometers developed with groups from GSI, CERN, and University of Notre Dame, as well as gamma-ray arrays and silicon detector systems comparable to JUROGAM, TIGRESS, and ISOLDE's Miniball projects. Laser spectroscopy setups draw on techniques from Institut Laue-Langevin and KU Leuven, while reaction chambers and scattering apparatus connect to experiments performed at RIKEN and TRIUMF's DRAGON facility.
Research at ISAC spans nuclear structure and shell-model tests linked to work by researchers from University of Surrey, University of Granada, and University of Warsaw, nuclear astrophysics studies relevant to processes studied by teams at California Institute of Technology and University of Notre Dame, and applied isotope production for medicine and industry connected with BC Cancer Agency and radiopharmacy groups at McMaster University. Collaborative projects extend to instrument development with CERN, joint experiments with GSI, and theoretical support from groups at Oak Ridge National Laboratory and TRIUMF Theory Group. ISAC-produced isotopes contribute to initiatives such as novel radiopharmaceutical development involving Health Canada stakeholders and isotope supply networks interacting with Canadian Nuclear Isotope Council partners.
ISAC operates under nuclear safety frameworks and oversight involving Canadian Nuclear Safety Commission, institutional radiation safety offices at TRIUMF, and standards referenced by the International Atomic Energy Agency. Radiation shielding, remote handling, and contamination controls are implemented to meet regulations used by facilities like Canadian Nuclear Laboratories and CNL partners, with emergency preparedness coordinated with local authorities including the City of Vancouver and provincial agencies. Worker training, dosimetry programs, and environmental monitoring follow practices adopted at CERN and other international accelerator facilities to ensure compliance and safe operations.
Category:TRIUMF Category:Radioactive ion beam facilities